Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114105414 | 11410541 | 4 | F | 20150903 | 20160711 | 20150824 | 20160727 | PER | US-PFIZER INC-2015261492 | PFIZER | 66.00 | YR | F | Y | 80.00000 | KG | 20160727 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114105414 | 11410541 | 1 | PS | IBRANCE | PALBOCICLIB | 1 | 125 MG, UNK | 207103 | 125 | MG | CAPSULE | ||||||||
| 114105414 | 11410541 | 2 | SS | IBRANCE | PALBOCICLIB | 1 | 100 MG, UNK | 207103 | 100 | MG | CAPSULE | ||||||||
| 114105414 | 11410541 | 3 | SS | IBRANCE | PALBOCICLIB | 1 | Oral | 100 MG, CYCLIC (FOR 21 DAYS ON AND 7 DAYS OFF) | 207103 | 100 | MG | CAPSULE | |||||||
| 114105414 | 11410541 | 4 | SS | FEMARA | LETROZOLE | 1 | Oral | 2.5 MG, DAILY | U | 0 | 2.5 | MG | TABLET | ||||||
| 114105414 | 11410541 | 5 | SS | FEMARA | LETROZOLE | 1 | Oral | 2.5 MG, 1X/DAY | U | 0 | 2.5 | MG | TABLET | QD | |||||
| 114105414 | 11410541 | 6 | C | XGEVA | DENOSUMAB | 1 | Subcutaneous | 1.7 ML, UNK (120 MG/1.7 ML (70 MG/ML) /EVERY 4 WEEKS) | 0 | 1.7 | ML | SOLUTION FOR INJECTION | |||||||
| 114105414 | 11410541 | 7 | C | ATIVAN | LORAZEPAM | 1 | Oral | 2 MG, AS NEEDED (2 TIMES EVERY DAY AS NEEDED) | 0 | 2 | MG | TABLET | |||||||
| 114105414 | 11410541 | 8 | C | CALCIUM 500+D | CALCIUMVITAMIN D | 1 | Oral | 1 DF, 2X/DAY ((1,250 MG)-200 UNIT TABLET) | 0 | 1 | DF | TABLET | BID | ||||||
| 114105414 | 11410541 | 9 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY (EVERY BEDTIME) | 0 | 10 | MG | TABLET | QD | ||||||
| 114105414 | 11410541 | 10 | C | DOXEPIN | DOXEPIN | 1 | Oral | 50 MG, 3X/DAY | 0 | 50 | MG | CAPSULE | TID | ||||||
| 114105414 | 11410541 | 11 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 100 UG, UNK [50 MCG/ACTUATION, 2 SPRAYS EACH NOSTRIL] | 0 | 100 | UG | NASAL SPRAY, SUSPENSION | |||||||
| 114105414 | 11410541 | 12 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, 2X/DAY (EVERY DAY WITH MORNING AND EVENING MEALS) | 0 | 1000 | MG | TABLET | BID | ||||||
| 114105414 | 11410541 | 13 | C | ONDANSETRON HYDROCHLORIDE. | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 8 MG, AS NEEDED (2 TIMES EVERY DAY AS NEEDED) | 0 | 8 | MG | TABLET | |||||||
| 114105414 | 11410541 | 14 | C | OXYCODONE | OXYCODONE | 1 | Oral | 15 MG, AS NEEDED (EVERY 5 HOURS PRN (DO NOT TAKE MORE THAN 5 TABLETS IN ONE DAY)) | 0 | 15 | MG | TABLET | |||||||
| 114105414 | 11410541 | 15 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 10 MEQ, ALTERNATE DAY (WITH FOOD) | 0 | 10 | MEQ | PROLONGED-RELEASE CAPSULE | QOD | ||||||
| 114105414 | 11410541 | 16 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Oral | 25 MG, AS NEEDED (EVERY 4 - 6 HOURS AS NEEDED) | 0 | 25 | MG | TABLET | |||||||
| 114105414 | 11410541 | 17 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 75 UG, 1X/DAY | 0 | 75 | UG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114105414 | 11410541 | 1 | Breast cancer stage IV |
| 114105414 | 11410541 | 4 | Breast cancer stage IV |
| 114105414 | 11410541 | 6 | Metastases to bone |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114105414 | 11410541 | Abdominal pain upper | |
| 114105414 | 11410541 | Breast cancer stage IV | |
| 114105414 | 11410541 | Cough | |
| 114105414 | 11410541 | Disease progression | |
| 114105414 | 11410541 | Fatigue | |
| 114105414 | 11410541 | Nasopharyngitis | |
| 114105414 | 11410541 | Nausea | |
| 114105414 | 11410541 | Vaginal haemorrhage | |
| 114105414 | 11410541 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114105414 | 11410541 | 1 | 20150731 | 0 | ||
| 114105414 | 11410541 | 2 | 201507 | 0 | ||
| 114105414 | 11410541 | 3 | 201508 | 0 | ||
| 114105414 | 11410541 | 4 | 201508 | 0 | ||
| 114105414 | 11410541 | 5 | 20160202 | 0 | ||
| 114105414 | 11410541 | 6 | 20140709 | 0 | ||
| 114105414 | 11410541 | 7 | 20120508 | 0 | ||
| 114105414 | 11410541 | 8 | 20121205 | 0 | ||
| 114105414 | 11410541 | 9 | 20120508 | 0 | ||
| 114105414 | 11410541 | 10 | 20120508 | 0 | ||
| 114105414 | 11410541 | 11 | 20151104 | 0 | ||
| 114105414 | 11410541 | 12 | 20120730 | 0 | ||
| 114105414 | 11410541 | 13 | 20160202 | 0 | ||
| 114105414 | 11410541 | 15 | 20160229 | 0 | ||
| 114105414 | 11410541 | 16 | 20160202 | 0 | ||
| 114105414 | 11410541 | 17 | 20140730 | 0 |